Neuropace Inc
NASDAQ:NPCE

Watchlist Manager
Neuropace Inc Logo
Neuropace Inc
NASDAQ:NPCE
Watchlist
Price: 11.83 USD -8.58%
Market Cap: 388m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
N/A
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

NPCE Price Targets Summary
Neuropace Inc

Wall Street analysts forecast NPCE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NPCE is 17.63 USD with a low forecast of 15.15 USD and a high forecast of 21 USD.

NPCE Lowest Forecast
Wall Street Target
15.15 USD
28% Upside
NPCE Average Forecast
Wall Street Target
17.63 USD
49% Upside
NPCE Highest Forecast
Wall Street Target
21 USD
78% Upside
Lowest
Price Target
15.15 USD
28% Upside
Average
Price Target
17.63 USD
49% Upside
Highest
Price Target
21 USD
78% Upside
Neuropace Inc Competitors:
Price Targets
145720
Dentium Co Ltd
49% Upside
ANGO
AngioDynamics Inc
47% Upside
SIBN
SI-BONE Inc
37% Upside
DIA
DiaSorin SpA
17% Upside
145720
Dentium Co Ltd
49% Upside
ANGO
AngioDynamics Inc
47% Upside
SIBN
SI-BONE Inc
37% Upside
DIA
DiaSorin SpA
17% Upside
FPH
Fisher & Paykel Healthcare Corporation Ltd
2% Upside
NYXH
Nyxoah SA
92% Upside
B
301367
BMC Medical Co Ltd
12% Upside
A
688617
APT Medical Inc
22% Upside

Revenue
Forecast

Revenue Estimate
Neuropace Inc

For the last 4 years the compound annual growth rate for Neuropace Inc's revenue is 18%. The projected CAGR for the next 3 years is 19%.

18%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Neuropace Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-6%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Neuropace Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-28%
Average Miss
What are analyst estimates?

See Also

Summary
NPCE intrinsic value, competitors valuation, and company profile.
DCF Valuation
NPCE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NPCE stock valuation using valuation multiples.
Wall Street Estimates
NPCE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NPCE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NPCE's stock price target?
Price Target
17.63 USD

According to Wall Street analysts, the average 1-year price target for NPCE is 17.63 USD with a low forecast of 15.15 USD and a high forecast of 21 USD.

What is Neuropace Inc's Revenue forecast?
Projected CAGR
19%

For the last 4 years the compound annual growth rate for Neuropace Inc's revenue is 18%. The projected CAGR for the next 3 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.